Overview

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

Status:
Completed
Trial end date:
2017-02-13
Target enrollment:
Participant gender:
Summary
Evaluation of safety, pharmacokinetics, and anti-psoriatic efficacy to assess SOR007 Ointment in topical formulations
Phase:
Phase 1
Details
Lead Sponsor:
DFB Soria, LLC
Collaborators:
Bioskin GmbH
US Biotest, Inc.
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Calcipotriene